Amanda Meszaros, DPM
Podiatrist · Oberlin, OHNPI 1447293204
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Arthrex at 38.2% of the total. Reporting peaked in 2022 at $4,145 and has fallen 87.4% since, to $522 in 2025.
Across 87 payments — averaging $75.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Rock Medical Orthopedics, Inc.$2K
- Smith+Nephew$530
- Johnson & Johnson$286
- Medtronic$279
- Stryker$203
- plus $793 from 15 others
What the payments were for
- Travel & lodging$1,64425%
- Food & beverage$2,55639%
- Education$2,40036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 23 | $2,524 |
| Rock Medical Orthopedics, Inc. | 6 | $1,984 |
| Smith+Nephew | 24 | $530 |
| Johnson & Johnson | 3 | $286 |
| Medtronic | 4 | $279 |
| Stryker(2 entities) | 5 | $203 |
| Inari Medical, Inc. | 1 | $125 |
| Organogenesis Inc. | 2 | $124 |
| Globus Medical | 2 | $105 |
| Bioventus LLC | 1 | $77 |
| Biopro, Inc. | 1 | $65 |
| Surgenex LLC | 2 | $57 |
| Mimedx Group, Inc. | 2 | $50 |
| Amgen | 3 | $37 |
| Melinta Therapeutics, LLC | 2 | $37 |
| Orthofix Medical, Inc. | 1 | $33 |
| Treace Medical Concepts, Inc. | 1 | $25 |
| Convatec Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Paragon 28, Inc. | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$250
- HawkOne$149
- FLOWTRIEVER CATHETER, S$125
- CT THROMBECTOMY SYSTEM KIT$125
- HAMMERLOCK$125
- VA-LCP$125
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$122
- VA-LCP PLATES & SCREWS$122
- ViviGen$122
- CANNULATED SCREWS$122
- INBONE$101
- INFINITY$101
- Apligraf$100
- Dermagraft$100
- Puraply/Affinity/NuTech$100
How this compares
$6,600 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 18 | $564 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $284 |
| Ammonium Lactate | 19 | $261 |
| Mupirocin | 17 | $165 |
| Ciprofloxacin Hcl | 14 | $114 |
| Doxycycline Hyclate | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Oberlin
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
- Daniel LoganGahanna$83K
- Howard KimmelBrookpark$67K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.